Pharmacy

Following its rival drugstore chain CVS Health, Walgreens plans to sell CBD creams, patches and sprays in 1,500 stores in nine states, according to CNBC.

Novartis won approval for its multiple sclerosis drug Mayzent, which will launch at a price of $88,000 annually, according to Reuters.

In the latest talc trial, a New Jersey jury decided Johnson & Johnson was not liable for causing a man's mesothelioma, according to CNBC. 

Three generic drugmakers — Teva Pharmaceuticals, Mylan and Ranbaxy —  will pay $65.9 million to settle claims that they engaged in a scheme promoting anticompetitive behavior, according to Reuters.

After a string of recalls linked to impurities or other contaminants in medications, the FDA plans to change the rules governing how drugs are manufactured to boost safety, according to Bloomberg.

Purdue Pharma and its billionaire family owners have made headlines this year as states and cities work through lawsuits claiming the OxyContin maker fueled the U.S. opioid crisis.

AstraZeneca will lay off 94 workers from its campus in the United Kingdom by 2020, according to online publication in-Pharmatechnologist.

Purdue Pharma and the billionaire Sackler family agreed to pay hundreds of millions to resolve the first of more than 1,600 lawsuits accusing the OxyContin maker of fueling the opioid crisis. The landmark deal could lay the groundwork for the resolution…

Louisiana officials will strike a deal with a Gilead Sciences subsidiary to supply hepatitis C medication under a Netflix-style payment model, according to STAT.

San Francisco-based Dignity Health opened its hospital-owned specialty pharmacy March 26.